Tirzepatide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists and is a GIP. By targeting both receptors, Tirzepatide enhances insulin secretion and reduces glucagon secretion in a glucose-dependent manner, contributing to improved glycemic control. In addition to its glucose-lowering effects, Tirzepatide has been associated with significant weight loss in clinical trials.
What’s Included:
Includes
Telehealth Visit (included), Tirzepatide
| Sunday | 12pm - 4pm |
|---|---|
| Monday | 8am - 6pm |
| Tuesday | 8am - 6pm |
| Wednesday | 8am - 6pm |
| Thursday | 8am - 6pm |
| Friday | Closed |
| Saturday | 5pm - 6pm |
Drop Us a Line